Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Palmoplantar Pustulosis: early-phase trial registry
1 of 2 indexed Palmoplantar Pustulosis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Palmoplantar Pustulosis: 2 US clinical trials tracked, 1 recruiting.
Palmoplantar Pustulosis is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), running 1 of these trials.
Enrollment posture brief
Registry condition palmoplantar-pustulosis
OPEN 1 | RECR 50% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Palmoplantar Pustulosis lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Palmoplantar Pustulosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Palmoplantar Pustulosis is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
LEO Pharma
NCT07013201
Anakinra for Inflammatory Pustular Skin Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT01794117
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Palmoplantar Pustulosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Palmoplantar Pustulosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Palmoplantar Pustulosis page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Palmoplantar Pustulosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) sponsors the most Palmoplantar Pustulosis trials on record, review their full trial history before evaluating a specific study. See National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Palmoplantar Pustulosis condition card totals 2 registered trials; most-linked intervention Anakinra; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.